Stryker vs. Zimmer Biomet vs. J&J: How they stack up in Q4

Stryker, Zimmer Biomet and Johnson and Johnson shared their financial results for the fourth quarter of 2021. 

Advertisement

Here’s how the companies’ results compare with the fourth quarter of 2021:

Stryker

Total revenue: $4.7 billion (+10.3 percent)

Total orthopedic and spine sales: $2.1 billion (+12.5 percent)

Hips: $352 million (+3.2 percent)

Knees: $523 million (+14.2 percent)

Spine: $300 million (-1.8 percent)

Zimmer Biomet

Total revenue: $2 billion (-2.3 percent)

Hips: $480.7 million (-4.6 percent)

Knees: $720.1 million (-0.8 percent)

Spine and dental: $260 million (-4.1 percent)

Johnson & Johnson

Total revenue: $24.8 billion (+10.4 percent)

Orthopedics: $2.2 billion (-1.6 percent)

Hips: $380 million (+2.1 percent)

Knees: $342 million (-0.9 percent)

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.